FELINE DISTEMPER VACCINE

Brand Owner (click to sort) Address Description
FEL-O-VAX ELANCO US INC. 2500 INNOVATION WAY GREENFIELD IN 46140 Feline Distemper Vaccine;
FELIN-TC PHILIPS ROXANE, INC. New York NY FELINE DISTEMPER VACCINE;FELINE TC;
FELIPAN RICHARDSON-MERRELL INC. Wilton CT FELINE DISTEMPER VACCINE;
FELOCELL ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 FELINE DISTEMPER VACCINE;
FELOCELL SMITHKLINE BEECHAN CORPORATION ONE FRANKLIN PLAZA, P.O. BOX 7929 PHILADELPHIA PA 19101 FELINE DISTEMPER VACCINE;
FELOCINE NORDEN LABORATORIES, INC. Lincoln NE FELINE DISTEMPER VACCINE, USED IN VETERINARY MEDICINE;
FELOID ARMOUR PHARMACEUTICAL COMPANY Phoenix AZ FELINE DISTEMPER VACCINE;
FEVAC FROMM LABORATORIES, INC. GRAFTON WI FELINE DISTEMPER VACCINE;
LEUKOGEN-TC PHILIPS ROXANE, INC. New York NY FELINE DISTEMPER VACCINE;TC;
PANAGEN Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 FELINE DISTEMPER VACCINE;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.